Who owns Talis Biomedical Corporation?
- Ticker: TLIS
- CUSIP Number: 87424l207
Tip: Access positions for across all investors
Analyze quarterly positions in Talis Biomedical Corporation with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Talis Biomedical Corporation stock
Who bought or sold Talis Biomedical Corporation this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BML Capital Management | 249k | $460k | 482% | Sep 2024 |
|
| Vanguard Group | 31k | $269k | 0% | Jun 2024 |
|
| BlackRock | 4.3k | $37k | -9% | Jun 2024 |
|
| Tower Research Capital | 877.00 | $7.6k | -5% | Jun 2024 |
|
| Steward Partners Investment Advisory | 147.00 | $1.3k | 100% | Jun 2024 |
|
| Morgan Stanley | 87.00 | $754.002900 | -86% | Jun 2024 |
|
| Qube Research & Technologies | 2.00 | $18.000000 | 0% | Jun 2024 |
|
Who sold out of Talis Biomedical Corporation?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Baker Bros. Advisors | Jun 2024 | 508k | $4.4M |
| DME Capital Management | Jun 2024 | 149k | $1.3M |
| Geode Capital Management | Jun 2024 | 14k | $123k |
| Renaissance Technologies | Jun 2024 | 12k | $107k |
| Susquehanna International | Jun 2024 | 12k | $102k |
| Advisor Group Holdings | Mar 2024 | 122.00 | $1.1k |
| Larson Financial Group | Jun 2024 | 14.00 | $121.000600 |
| Bank of America Corporation | Jun 2024 | 13.00 | $112.999900 |
| Jpmorgan Chase & Co | Jun 2024 | 3.00 | $26.000100 |